Institutional members access full text with Ovid®

Share this article on:

Imaging of Ischemic Stroke

Lin, Michelle P. MD, MPH; Liebeskind, David S. MD, FAAN

CONTINUUM: Lifelong Learning in Neurology: October 2016 - Volume 22 - Issue 5, Neuroimaging - p 1399–1423
doi: 10.1212/CON.0000000000000376
Review Articles

ABSTRACT Purpose of Review: This article provides an overview of cerebrovascular hemodynamics, acute stroke pathophysiology, and collateral circulation, which are pivotal in the modern imaging of ischemic stroke that guides the care of the patient with stroke.

Recent Findings: Neuroimaging provides extensive information on the brain and vascular health. Multimodal CT and MRI delineate the hemodynamics of ischemic stroke that may be used to guide treatment decisions and prognosticate regarding expected outcomes. Mismatch imaging with either CT or MRI may identify patients with salvageable regions who are at risk and likely to benefit from reperfusion therapy, even if they are outside the standard time window. Imaging of collateral circulation and determination of collateral grade may predict greater reperfusion, lower hemorrhage risk, and better functional outcome. Current neuroimaging technology also enables the identification of patients at high risk of hemorrhagic transformation or those who may be harmed by treatment or unlikely to benefit from it.

Summary: This article reviews the use and impact of imaging for the patient with ischemic stroke, emphasizing how imaging builds upon clinical evaluation to establish diagnosis or etiology, reveal key pathophysiology, and guide therapeutic decisions.

Address correspondence to Dr David S. Liebeskind, Neurovascular Imaging Research Core, UCLA Department of Neurology, Neuroscience Research Building, 635 Charles E. Young Dr S, Suite 225, Los Angeles, CA 90095, davidliebeskind@yahoo.com.

Relationship Disclosure: Dr Lin reports no disclosure. Dr Liebeskind has served as an associate editor of the Journal of Neuroimaging and as a consultant to the imaging core laboratories of Medtronic and Stryker. Dr Liebeskind receives royalties from UpToDate, Inc, and grant/research support from the National Institutes of Health.

Unlabeled Use of Products/Investigational Use Disclosure: Drs Lin and Liebeskind report no disclosures.

© 2016 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website